Literature DB >> 2853748

Stimulation of the phosphoinositide signalling system as a possible mechanism for glucocorticoid action in blood pressure control.

A Steiner1, E Vogt, R Locher, W Vetter.   

Abstract

Cortisol stimulates the phosphoinositide signalling system in smooth muscle cells of the rat aorta. After stimulation of the cells with cortisol, epinephrine or both compounds, inositol-1,4,5-trisphosphate concentrations were analysed by standardized ion-exchange chromatography procedure. A 15-min stimulation with physiological concentrations of cortisol (0.02-5.0 microgram/ml) led to a dose-dependent increase of the inositol trisphosphate concentrations (up to 500%) and also to a translocation of the calcium- and lipid-dependent protein kinase C activity from the cytosolic to the membranous compartment. Incubation of smooth muscle cells with epinephrine (10(-9) to -5 mol/l) did not lead to an increase in the inositol trisphosphate concentrations. However, after pre-incubation with an average dose of cortisol (0.2 microgram/ml) the inositol trisphosphate response was potentiated by 10(-7) mol/l epinephrine. Our results suggest that stimulation of the phosphoinositide system is a still unknown mechanism of glucocorticoid action in smooth muscle cells, which could influence intracellular free calcium and thus vascular reactivity and blood pressure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853748     DOI: 10.1097/00004872-198812040-00114

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  9 in total

1.  Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids.

Authors:  Florian P Limbourg; Zhihong Huang; Jean-Christophe Plumier; Tommaso Simoncini; Masayuki Fujioka; Jan Tuckermann; Günther Schütz; Michael A Moskowitz; James K Liao
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Rapid non-genomic inhibition of ATP-induced Cl- secretion by dexamethasone in human bronchial epithelium.

Authors:  V Urbach; D E Walsh; B Mainprice; J Bousquet; B J Harvey
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

Review 3.  Nontranscriptional actions of the glucocorticoid receptor.

Authors:  Florian P Limbourg; James K Liao
Journal:  J Mol Med (Berl)       Date:  2003-03-14       Impact factor: 4.599

Review 4.  Non-genomic Effects of Glucocorticoids: An Updated View.

Authors:  Reynold A Panettieri; Dedmer Schaafsma; Yassine Amrani; Cynthia Koziol-White; Rennolds Ostrom; Omar Tliba
Journal:  Trends Pharmacol Sci       Date:  2018-11-26       Impact factor: 14.819

5.  Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells.

Authors:  Jamie D Croxtall; Peter Th W van Hal; Qam Choudhury; Derek W Gilroy; Rod J Flower
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 6.  [Adrenal cortex and steroids. Supplementary therapy in the perioperative phase].

Authors:  A S Milde; B W Böttiger; M Morcos
Journal:  Anaesthesist       Date:  2005-07       Impact factor: 1.041

7.  Role of nitric oxide on purinergic signalling in the cochlea.

Authors:  Narinobu Harada
Journal:  Purinergic Signal       Date:  2010-06-08       Impact factor: 3.765

Review 8.  Non-genomic effect of glucocorticoids on cardiovascular system.

Authors:  Sung Ryul Lee; Hyoung Kyu Kim; Jae Boum Youm; Louise Anne Dizon; In Sung Song; Seung Hun Jeong; Dae Yun Seo; Kyoung Soo Ko; Byoung Doo Rhee; Nari Kim; Jin Han
Journal:  Pflugers Arch       Date:  2012-09-23       Impact factor: 3.657

Review 9.  Looking beyond the dogma of genomic steroid action: insights and facts of the 1990s.

Authors:  M Wehling
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.